These observations together indicate that IPS/FVS-specific CD8+ T cells might be able to reduce SARS-CoV-2 spread at initial infection but likely do not play a significant role in the pathogenesis of severe COVID-19. The gene discussed is CD8A; the disease is COVID-19.